Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Francesca Milletti

发表论文 53 篇 · 总被引 3724 次 · h-index 20

代表论文

  • KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study (2021 · The Lancet · 被引 797)
  • Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial (2022 · Nature Medicine · 被引 288)
  • Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition (2019 · Science Signaling · 被引 244)
  • CD19-Loss with Preservation of Other B Cell Lineage Features in Patients with Large B Cell Lymphoma Who Relapsed Post-Axi-Cel (2019 · Blood · 被引 75)
  • Interim Analysis of ZUMA-12: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) as First-Line Therapy in Patients (Pts) With High-Risk Large B Cell Lymphoma (LBCL) (2020 · Blood · 被引 44)
  • Inhibition of IRF5 cellular activity with cell-penetrating peptides that target homodimerization (2020 · Science Advances · 被引 29)